For the US readers and contributers

Dr. Gregory Acland, whose research led to the discovery of the crd3 mutation at Cornell University and UPenn, will be at the New England Glen Gathering on Saturday September 18th in Barre, MA.  He will be performing eye exams and giving a research update.  Optigen will also be there to take samples for the DNA mutation test as part of a 20/20 clinic. 

Contact Martha Parry (mfparry@sbcglobal.net) or Ara Lynn (603-878-3552) for more information.